Evidence-based·Updated November 20, 2026·How we grade evidence

Alendronate

MedicationBisphosphonate (prescription)

Alendronate is a weekly or daily bisphosphonate with strong trial evidence: in a Cochrane review of 11 trials in 12,068 postmenopausal women, 10 mg a day cut vertebral fractures by 45% and, in women who already had a fracture, hip and other fractures too. It only works if absorbed, so coffee and calcium taken with the dose are both rated high-severity interactions.

Taking Alendronate with other supplements or medications?Check your whole list for interactions. Free, no account.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Postmenopausal women and men with osteoporosis, people on long-term steroid medicines with low bone density, and people with Paget's disease of bone, when a prescriber recommends it

Common dosing range

Set by your prescriber. The labels list 70 mg once weekly (or 10 mg daily) to treat osteoporosis in women and men, 35 mg weekly or 5 mg daily to prevent it, 5 mg daily (10 mg in postmenopausal women not on estrogen) for steroid-induced osteoporosis, and 40 mg daily for 6 months for Paget's disease

When to expect effects

The label says increases in bone density were seen as early as 3 months; fracture reductions in trials were measured over 3 to 4 years

Watch out for

Esophageal irritation and ulcers if it is not taken upright with a full glass of plain water. Not for people with esophagus problems that delay emptying, who cannot stay upright for 30 minutes, or who have low blood calcium. Rare jaw osteonecrosis and atypical thigh fractures

What is it

Alendronate is a prescription bisphosphonate, a medicine that slows bone loss. It is sold as generic alendronate sodium tablets, as Fosamax 70 mg tablets taken once a week, and as Binosto, a 70 mg effervescent tablet dissolved in water. The Fosamax label approves it to treat and prevent osteoporosis after menopause, to increase bone mass in men with osteoporosis, to treat osteoporosis caused by steroid (glucocorticoid) medicines, and to treat Paget's disease of bone. It has no boxed warning. Because the body absorbs less than 1% of each dose, how you take it matters: food, coffee, juice, mineral water and calcium can all block it.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have osteoporosis or a prior fragility fracture and your prescriber recommends alendronate
You take steroid medicines long term (7.5 mg a day of prednisone or more) and have low bone density
You can take it first thing in the morning with plain water, stay upright for 30 minutes and wait before eating, drinking or taking other medicines

Probably skip if…

You have an esophagus problem that delays emptying, such as a stricture or achalasia (contraindicated)
You cannot stand or sit upright for at least 30 minutes, or you have low blood calcium that has not been corrected (contraindicated)
Your kidney function is very low (creatinine clearance under 35 mL/min), where the label says it is not recommended
You plan to take it with coffee, juice or your calcium supplement, which can leave the dose largely unabsorbed

Evidence at a glance

spine fractures in postmenopausal osteoporosis

Strong Evidence
Effect
Large; about 45% fewer spine fractures
Best fit
Postmenopausal women with osteoporosis, especially those with a prior spine fracture
Time
Measured over 3 to 4 years

hip and other fractures in women who already had a fracture

Strong Evidence
Effect
Moderate to large in secondary prevention; not significant for hip and non-spine fractures in primary prevention
Best fit
Postmenopausal women with a prior fracture or bone density in the osteoporosis range
Time
Measured over 3 to 4 years

osteoporosis in men

Good Evidence
Effect
Spine density up 7.1% versus 1.8% on placebo
Best fit
Men with osteoporosis, with or without low testosterone
Time
Measured over 2 years

bone loss from steroid (glucocorticoid) medicines

Good Evidence
Effect
Spine density up 2.1% to 2.9% versus a 0.4% fall on placebo
Best fit
Adults on long-term glucocorticoids with low bone density
Time
Measured over 48 weeks

continuing beyond 5 years for non-spine fractures

Good Evidence
Effect
No difference in non-spine fractures; fewer clinical spine fractures when continued
Best fit
Women who have completed about 5 years of alendronate
Time
Measured over 5 additional years

Evidence for 5 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

spine fractures in postmenopausal osteoporosis

Disease adjunct
Strong Evidence

A Cochrane review of 11 randomized trials in 12,068 postmenopausal women found that alendronate 10 mg a day lowered vertebral fractures by 45% (risk ratio 0.55), both in women without a prior fracture (about 2% absolute reduction) and in women with one (about 6%). In the Fracture Intervention Trial of 2,027 women aged 55 to 81 with low hip bone density and an existing spine fracture, new spine fractures on X-ray fell from 15.0% to 8.0% over 3 years, and painful (clinical) spine fractures from 5.0% to 2.3%. An earlier 3-year trial in 994 women found new spine fractures in 3.2% versus 6.2% on placebo.

Effect size
Large; about 45% fewer spine fractures
Time to effect
Measured over 3 to 4 years
Best fit
Postmenopausal women with osteoporosis, especially those with a prior spine fracture
Less likely
Women with higher bone density and no fracture, whose absolute benefit is small

Bottom line: Alendronate reliably cuts spine fractures in women with osteoporosis.

hip and other fractures in women who already had a fracture

Disease adjunct
Strong Evidence

In the Cochrane review, alendronate 10 mg a day lowered non-spine fractures by 23% and hip fractures by 53% (about 1% absolute) in women who already had a fracture (secondary prevention). For women without a prior fracture (primary prevention), the reductions in non-spine and hip fractures were not statistically significant. In the 4-year FIT arm of 4,432 women with low bone density but no spine fracture, clinical fractures fell 36% only in those with osteoporosis-range hip density, with no significant reduction in women with higher density.

Effect size
Moderate to large in secondary prevention; not significant for hip and non-spine fractures in primary prevention
Time to effect
Measured over 3 to 4 years
Best fit
Postmenopausal women with a prior fracture or bone density in the osteoporosis range
Less likely
Women with low bone mass above the osteoporosis range and no prior fracture

Bottom line: The hip and non-spine fracture benefit is clearest in women who already have osteoporosis or a fracture.

Evidence is mixed

Primary-prevention results for hip and non-spine fractures were not statistically significant in the Cochrane review, and FIT found no clinical fracture reduction in women whose hip density was above the osteoporosis range.

osteoporosis in men

Biomarker support
Good Evidence

In a 2-year double-blind trial of 241 men aged 31 to 87 (mean 63) with osteoporosis, all given calcium and vitamin D, alendronate 10 mg a day raised spine bone density by 7.1% versus 1.8% on placebo and hip (femoral neck) density by 2.5%. Spine fractures on X-ray occurred in 0.8% versus 7.1%, and height loss was smaller (0.6 vs 2.4 mm). Men with other secondary causes of osteoporosis were excluded, and the trial was not designed around fractures.

Effect size
Spine density up 7.1% versus 1.8% on placebo
Time to effect
Measured over 2 years
Best fit
Men with osteoporosis, with or without low testosterone
Less likely
Men whose bone loss has another untreated secondary cause

Bottom line: Alendronate raises bone density in men with osteoporosis, and one trial also found fewer spine fractures.

bone loss from steroid (glucocorticoid) medicines

Biomarker support
Good Evidence

Two 48-week placebo-controlled trials enrolled 477 men and women aged 17 to 83 taking glucocorticoids. Spine bone density rose 2.1% on 5 mg and 2.9% on 10 mg a day, while it fell 0.4% on placebo; hip density also rose. New spine fractures were 2.3% versus 3.7%, a difference too small to be certain (relative risk 0.6, 95% CI 0.1 to 4.4). There was a small increase in nonserious stomach side effects on 10 mg.

Effect size
Spine density up 2.1% to 2.9% versus a 0.4% fall on placebo
Time to effect
Measured over 48 weeks
Best fit
Adults on long-term glucocorticoids with low bone density
Less likely
People on prednisone below 7.5 mg a day, for whom the label says the benefit has not been established

Bottom line: Alendronate protects bone density in people on steroid medicines; a fracture benefit was not proven in these trials.

continuing beyond 5 years for non-spine fractures

No benefit found
Good Evidence

In the FLEX trial, 1,099 postmenopausal women who had taken alendronate for about 5 years were randomized to keep taking it (5 or 10 mg a day) or switch to placebo for 5 more years. Non-spine fractures did not differ (19% continuing vs 18.9% stopping; relative risk 1.00), and spine fractures seen only on X-ray were not significantly reduced (9.8% vs 11.3%). Women who continued had fewer clinically recognized spine fractures (2.4% vs 5.3%; relative risk 0.45), and bone density fell modestly in those who stopped. Fractures were an exploratory outcome; the main outcome was hip bone density.

Effect size
No difference in non-spine fractures; fewer clinical spine fractures when continued
Time to effect
Measured over 5 additional years
Best fit
Women who have completed about 5 years of alendronate
Less likely
Women at very high risk of spine fractures, who the authors said may benefit from continuing

Bottom line: After 5 years, many women can pause alendronate without more non-spine fractures, but this is a decision for your prescriber.

Evidence is mixed

Continuing did lower clinically recognized spine fractures (2.4% vs 5.3%), so women at high spine-fracture risk may still benefit.

How it works

Alendronate binds to bone mineral and blocks osteoclasts, the cells that break bone down. Slower breakdown lets bone density rise over months and lowers the chance of fractures, especially in the spine. The label says it stays in the skeleton for years, with an estimated terminal half-life of more than 10 years. Absorption is the weak point. The label says average oral bioavailability is only 0.64% even when taken correctly after an overnight fast, is negligible when taken with or up to two hours after breakfast, and falls by about 60% with coffee or orange juice. Calcium, antacids and other medicines containing minerals such as magnesium, aluminum or iron bind it in the gut. That is why the label says to take it first thing in the morning with plain water only, at least 30 minutes before any food, drink or other medicine, and to stay upright to protect the esophagus.

How to take it

1. Typical dose
Your prescriber sets the dose. The Fosamax label lists: postmenopausal osteoporosis and osteoporosis in men, 70 mg once weekly or 10 mg once daily; prevention in postmenopausal women, 35 mg once weekly or 5 mg once daily; glucocorticoid-induced osteoporosis, 5 mg once daily, or 10 mg once daily in postmenopausal women not taking estrogen; Paget's disease, 40 mg once daily for 6 months. Binosto is one 70 mg effervescent tablet once weekly for osteoporosis in postmenopausal women and men.
2. Higher studied dose
The highest labeled dose is 40 mg a day for 6 months for Paget's disease. In the FLEX trial, women who had already taken alendronate for about 5 years were randomized to 5 or 10 mg a day or placebo for 5 more years.
3. Timing
Once a week on the same day (or once daily), first thing after getting up for the day, at least 30 minutes before the first food, drink or other medicine. The label says not to take it at bedtime or before getting up. If you miss a weekly dose, the label says to take it the morning after you remember and then go back to your usual day; never take two doses on the same day.
4. With food
Never with food. Fosamax tablets are swallowed whole with a full glass (6 to 8 ounces) of plain water. Binosto is dissolved in 4 ounces of plain room-temperature water (not mineral or flavored water); wait at least 5 minutes after the fizzing stops, stir for about 10 seconds and drink it. The label says other drinks, including mineral water, coffee and juice, and food lower absorption.
5. Split dosing
Not split. One weekly dose or one daily dose, as prescribed.
6. How long to try
Your prescriber decides. The label says the best length of treatment is not known, the need to continue should be checked from time to time, and stopping after 3 to 5 years can be considered for people at low fracture risk.

What to track

Trouble or pain swallowing, chest pain behind the breastbone, or new or worse heartburn (the label says to stop and get medical attention)
New thigh, hip or groin pain, which can come before an atypical femur fracture
Jaw pain, loose teeth or slow healing after dental work; tell your dentist you take alendronate
Severe bone, joint or muscle pain
Calcium and vitamin D intake, and bone density scans as your prescriber schedules them

Bottom line: Your prescriber sets the dose; take it first thing with plain water only, stay upright, and wait at least 30 minutes before coffee, food, calcium or other medicines.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Belly pain, heartburn or acid regurgitation, indigestion and nauseaConstipation, diarrhea or gasBone, muscle or joint painHeadache

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Pregnancy: the Fosamax label says available data in pregnant women are not enough to show a drug-associated risk, and to stop it when pregnancy is recognized. Because bisphosphonates are stored in bone and released over years, the label says there is a potential risk of harm to the baby's skeleton even if pregnancy happens after a course of treatment has ended; how the time since stopping affects that risk has not been studied. Discuss pregnancy plans with your doctor. Breastfeeding: the label says it is not known whether alendronate is present in human milk or affects milk production or the breastfed infant, and that the benefits of breastfeeding should be weighed with the mother's need for the medicine.

Interactions

CoffeeHigh

In bioavailability studies in postmenopausal women, black coffee taken with alendronate reduced the amount absorbed by about 60%, on top of an absorption that is already under 1%; orange juice did the same, and taking it with breakfast cut absorption by more than 85%. The label says to take it with plain water only and to wait at least 30 minutes before the first food or drink of the day. Have your coffee after that wait.

Calcium supplementsHigh

The label says calcium, antacids and oral medicines containing multivalent minerals interfere with alendronate absorption, and to wait at least 30 minutes after the dose before taking any other oral medicine. Calcium itself is still recommended when your diet is short of it, so take it later in the day, for example with a meal, and ask your pharmacist to set the timing.

Antacids and other medicines containing magnesium, aluminum or ironHigh

The label says antacids and oral medications containing multivalent cations interfere with alendronate absorption. Take them no sooner than 30 minutes after alendronate, and ask your pharmacist about longer gaps for your other medicines.

Orange juiceHigh

In bioavailability studies done mainly in postmenopausal women, orange juice taken with alendronate reduced the amount absorbed by about 60%, on top of an absorption of only about 0.76% with water. The label says even dosing with orange juice markedly reduces absorption. Take alendronate with plain water only and have juice at least 30 minutes later.

Mineral waterHigh

The label says to take alendronate with plain water only, that other beverages (including mineral water) are likely to reduce its absorption, and not to take it with mineral water. No study has measured how much mineral water lowers absorption. Use plain tap or bottled water and wait at least 30 minutes before other drinks.

Iron supplementsHigh

The label says oral products containing multivalent cations interfere with alendronate absorption, and iron is one of these minerals; no study has measured iron with alendronate. Take alendronate first with plain water and iron no sooner than 30 minutes later, the label's rule for other oral medicines; later in the day is simplest. Ask your pharmacist to set the timing.

Magnesium supplementsHigh

The label says calcium, antacids and oral products containing multivalent cations interfere with alendronate absorption, and magnesium is one of these minerals; no study has measured magnesium with alendronate. Take alendronate first with plain water and magnesium no sooner than 30 minutes later, the label's rule for other oral medicines; later in the day is simplest.

Aspirin and NSAIDs (ibuprofen, naproxen)Moderate

The label says upper stomach and esophagus side effects were more common in people taking alendronate doses above 10 mg a day with aspirin products. In a 3-year trial where most people also used NSAIDs, side effects were similar to placebo, but the label still advises caution because NSAIDs irritate the stomach. Tell your prescriber if you use them regularly.

Documented interactions

Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.

Warnings (6)

+ calcium

high

Calcium and other multivalent minerals interfere with the absorption of alendronate, a drug that is already very poorly absorbed (under 1% of a dose taken with water on an empty stomach). The Fosamax label says taking it with calcium, antacids, or oral medications containing multivalent cations will interfere with absorption. Taken together, the calcium can leave the osteoporosis drug much less effective.

+ coffee

high

Coffee (and orange juice) sharply reduce the absorption of alendronate, an oral bisphosphonate whose baseline absorption is already very low. Taking the tablet with coffee instead of plain water can cut the absorbed amount enough to make the dose ineffective for protecting bone.

+ iron

high

Alendronate is barely absorbed (less than 1% of a dose), and its label says calcium, antacids and oral products containing multivalent minerals interfere with its absorption. Iron is a multivalent mineral, so taking it at the same time could lower the amount of alendronate absorbed and reduce protection for bone. The evidence is the label's statement for this group of minerals; no study has measured iron with alendronate.

+ magnesium

high

Alendronate is barely absorbed (less than 1% of a dose), and its label says calcium, antacids and oral products containing multivalent minerals interfere with its absorption. Magnesium is a multivalent mineral and is found in many antacids, so taking it at the same time could lower the amount of alendronate absorbed and reduce protection for bone. The evidence is the label's statement for this group of minerals; no study has measured magnesium with alendronate.

See all 6 Alendronate interactions →

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

Fosamax or generic alendronate sodium tablets dispensed on your own prescription; Fosamax is now marketed as a 70 mg weekly tablet
Binosto 70 mg effervescent tablets, which are dissolved in plain water, not swallowed whole
Fosamax Plus D also contains vitamin D3 (cholecalciferol); check whether you are taking a combination product before adding more vitamin D
A Patient Information leaflet that explains the morning water-only routine

Be skeptical of…

Bone supplements marketed as a replacement for prescribed osteoporosis treatment
Advice to take calcium, a multivitamin or coffee together with your alendronate dose
Advice to take it at bedtime or lie down afterward
Online sellers offering alendronate without a prescription

Frequently asked questions

Can I drink coffee with alendronate?⌄

Not with the dose. Black coffee lowered absorption by about 60% in studies, and this page rates coffee a high-severity interaction. Take alendronate with plain water only and wait at least 30 minutes, as the label says, before your coffee or breakfast.

Can I take my calcium supplement with alendronate?⌄

Not at the same time. The label says calcium and antacids interfere with absorption, and this page rates calcium a high-severity interaction. You may still need calcium; take it later in the day, such as with a meal, and ask your pharmacist to help with timing.

Can I take alendronate with mineral water or juice?⌄

The label says to take it with plain water only, and that other drinks, including mineral water, lower absorption. In absorption studies, orange juice taken with the dose cut absorption by about 60%. For Binosto, the label says to dissolve the tablet in plain room-temperature water, not mineral or flavored water.

Why do I have to stay upright after taking it?⌄

Alendronate can irritate the esophagus. The label says to swallow the tablet with a full glass of plain water and not to lie down for at least 30 minutes and until after your first food of the day. Stop and get medical advice if you develop pain or trouble swallowing, chest pain or new heartburn.

How long should I take alendronate?⌄

Your prescriber decides. The label says the best length of treatment is not known and that people at low fracture risk may be considered for stopping after 3 to 5 years. In the FLEX trial, stopping after 5 years did not raise non-spine fractures, but women who continued had fewer clinical spine fractures.

References by claim

spine fractures in postmenopausal osteoporosis

Wells et al., 2008 · PubMed (2008) link

Black et al., 1996 · PubMed (1996) link

Liberman et al., 1995 · PubMed (1995) link

hip and other fractures in women who already had a fracture

Cummings et al., 1998 · PubMed (1998) link

osteoporosis in men

Orwoll et al., 2000 · PubMed (2000) link

bone loss from steroid (glucocorticoid) medicines

Saag et al., 1998 · PubMed (1998) link

continuing beyond 5 years for non-spine fractures

Black et al., 2006 · PubMed (2006) link

Safety

Fosamax (alendronate sodium) prescribing information · DailyMed (FDA label) link

Interaction: Coffee

Gertz et al., 1995 · PubMed (1995) link

Track Alendronate with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 20, 2026·Evidence current as of Nov 20, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.